September 29, 2025 - Life sciences transactions necessarily result in intellectual property (IP) due diligence being carried out on the underlying IP assets that are often a central part of the ...
As companies and markets increasingly view patents not just as a defensive shield but as strategic assets (e.g., for licensing, enforcement, or other potential revenue generation), the prosecution ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback